Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxoprofen Hydrogel Patch vs Tablet in Ankylosing Spondylitis
NCT03800797Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of loxoprofen in ankylosing spondylitis (AS) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Assessment in Ankylosing Spondylitis 20% response at 4 weeks. Started May 2015; status: completed.
02
Drugs
loxoprofen
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT03800797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800797.